These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6677267)

  • 1. [Anti-tetanus vaccines].
    Bizzini B
    Boll Ist Sieroter Milan; 1983; 62(6):550-4. PubMed ID: 6677267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
    Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP
    Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Simultaneous prophylaxis against tetanus with tetanus vaccine and human anti-tetanus globulin].
    Züst B
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Mar; 132(3):261-75. PubMed ID: 4232739
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetanus.
    Feery BJ
    Aust Fam Physician; 1981 Mar; 10(3):177-80. PubMed ID: 7247851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.
    Hong HA; Ke NT; Nhon TN; Thinh ND; van der Gun JW; Hendriks JT; Kreeftenberg JG
    Bull World Health Organ; 1996; 74(3):275-82. PubMed ID: 8789926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological characteristics of specific IgE for tetanus toxoid].
    Miadonna A
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):554-9. PubMed ID: 7248090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-tetanus serum or anatoxin?].
    Grosbuis S
    Rev Prat; 1974 Nov; 24(51):4505-6, 4509-11. PubMed ID: 4475480
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-tetanus vaccines, serums and immunoglobulins].
    Pontecorvo M
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):448-54. PubMed ID: 7248073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current trends in the use of combined serum and vaccine in tetanus prevention].
    Olivo R; Fabio U
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of tetanus].
    Grosbuis S; Goulon M
    Rev Prat; 1998 Mar; 48(5):478-81. PubMed ID: 9781108
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental study upon the efficacy of some accelerated vaccination schedules in tetanus prophylaxis.
    Dimache G; Croitoru M; Durbaca S; Stoean C; Dimache A
    Roum Arch Microbiol Immunol; 1993; 52(4):247-54. PubMed ID: 7827361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitetanus and antidiphtheria immunity in newborns.
    Durbacă S
    Roum Arch Microbiol Immunol; 1999; 58(3-4):267-72. PubMed ID: 11845464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitetanus vaccination].
    Rapin M; Nouailhat F
    Presse Med (1893); 1967 Apr; 75(17):839-40. PubMed ID: 6021367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological prevention of tetanus in hospitals: practical notes].
    Di Rocco P
    Ig Mod; 1970; 63(1):38-46. PubMed ID: 4098587
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mass antitetanus vaccination in Africa].
    Rey M; Diop Mar I; Gbezo P; Sow A
    Nouv Presse Med; 1973 Feb; 2(8):514. PubMed ID: 4689353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.